Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |